Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Asset Writedowns and Impairment (2018 - 2023)

Milestone Scientific's Asset Writedowns and Impairment history spans 7 years, with the latest figure at $8789.0 for Q4 2023.

  • For Q4 2023, Asset Writedowns and Impairment changed N/A year-over-year to $8789.0; the TTM value through Sep 2025 reached $8789.0, down 99.22%, while the annual FY2023 figure was $24865.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2023 was $8789.0 at Milestone Scientific, down from $308000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $308000.0 in Q2 2020 and bottomed at $8789.0 in Q4 2023.